PL2204174T3 - Sposób solubilizacji metronidazolu za pomocą niacynamidu i dwóch glikoli oraz roztwór otrzymany w ten sposób - Google Patents
Sposób solubilizacji metronidazolu za pomocą niacynamidu i dwóch glikoli oraz roztwór otrzymany w ten sposóbInfo
- Publication number
- PL2204174T3 PL2204174T3 PL10160846T PL10160846T PL2204174T3 PL 2204174 T3 PL2204174 T3 PL 2204174T3 PL 10160846 T PL10160846 T PL 10160846T PL 10160846 T PL10160846 T PL 10160846T PL 2204174 T3 PL2204174 T3 PL 2204174T3
- Authority
- PL
- Poland
- Prior art keywords
- metronidazole
- niacinamide
- glycols
- resulting solution
- glycolic
- Prior art date
Links
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 title abstract 5
- 229960000282 metronidazole Drugs 0.000 title abstract 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 title abstract 3
- 229960003966 nicotinamide Drugs 0.000 title abstract 3
- 235000005152 nicotinamide Nutrition 0.000 title abstract 3
- 239000011570 nicotinamide Substances 0.000 title abstract 3
- 150000002334 glycols Chemical class 0.000 title 1
- 239000000243 solution Substances 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 239000008346 aqueous phase Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 abstract 1
- 230000003381 solubilizing effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cephalosporin Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0506182A FR2887149B1 (fr) | 2005-06-17 | 2005-06-17 | Procede de solubilisation du metronidazole |
| EP10160846A EP2204174B1 (fr) | 2005-06-17 | 2006-06-16 | Procédé de solubilisation du metronidazole a l'aide de niacinamide et de deux glycols, solution ainsi obtenue |
| EP06778604A EP1896016B1 (fr) | 2005-06-17 | 2006-06-16 | Procede de solubilisation du metronidazole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2204174T3 true PL2204174T3 (pl) | 2012-10-31 |
Family
ID=35597783
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06778604T PL1896016T3 (pl) | 2005-06-17 | 2006-06-16 | Sposób solubilizacji metronidazolu |
| PL10160846T PL2204174T3 (pl) | 2005-06-17 | 2006-06-16 | Sposób solubilizacji metronidazolu za pomocą niacynamidu i dwóch glikoli oraz roztwór otrzymany w ten sposób |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06778604T PL1896016T3 (pl) | 2005-06-17 | 2006-06-16 | Sposób solubilizacji metronidazolu |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US7981916B2 (pl) |
| EP (2) | EP2204174B1 (pl) |
| AT (1) | ATE476976T1 (pl) |
| CA (1) | CA2611883A1 (pl) |
| CY (2) | CY1110807T1 (pl) |
| DE (1) | DE602006016122D1 (pl) |
| DK (2) | DK1896016T3 (pl) |
| ES (2) | ES2388236T3 (pl) |
| FR (1) | FR2887149B1 (pl) |
| PL (2) | PL1896016T3 (pl) |
| PT (2) | PT2204174E (pl) |
| SI (2) | SI2204174T1 (pl) |
| WO (1) | WO2006134279A2 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2887149B1 (fr) * | 2005-06-17 | 2007-08-03 | Galderma Sa | Procede de solubilisation du metronidazole |
| GB0615016D0 (en) * | 2006-07-28 | 2006-09-06 | Flen Pharma N V | Use of polyethylene glycol in inflammation related topical disorders or diseases and wound healing |
| WO2010047831A1 (en) * | 2008-10-23 | 2010-04-29 | Nycomed Us Inc. | Stable metronidazole gel formulations |
| BR112013033759B1 (pt) * | 2011-06-28 | 2021-05-25 | Chemo Research Sl | forma de dosagem unitária de um gel de base aquosa de metronidazol mucoadesivo e uso relacionado ao gel de base aquosa de metronidazol |
| TWI805601B (zh) | 2017-08-11 | 2023-06-21 | 南韓商愛茉莉太平洋股份有限公司 | 醫藥組成物及抑制其形成結晶的方法 |
| CN115957213A (zh) * | 2022-12-30 | 2023-04-14 | 青岛市胶州中心医院 | 一种抗感染甲硝唑制剂及其制备方法 |
| CN118743678A (zh) * | 2024-06-07 | 2024-10-08 | 中国药科大学 | 一种甲硝唑药物乳剂组合物及其制备方法和应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4032645A (en) * | 1975-06-19 | 1977-06-28 | G. D. Searle & Co. | Injectable metronidazole composition |
| JPS5859913A (ja) * | 1981-10-06 | 1983-04-09 | Wakoudou Kk | ジアゼパム注腸液 |
| US4837378A (en) | 1986-01-15 | 1989-06-06 | Curatek Pharmaceuticals, Inc. | Topical metronidazole formulations and therapeutic uses thereof |
| US5536743A (en) | 1988-01-15 | 1996-07-16 | Curatek Pharmaceuticals Limited Partnership | Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
| FR2722098B1 (fr) | 1994-07-06 | 1996-08-23 | Cird Galderma | Nouveaux medicaments a base de metro-nidazole ou d'un melange synergetique de metronidazole et de clindamycine |
| US6444647B1 (en) * | 1999-04-19 | 2002-09-03 | The Procter & Gamble Company | Skin care compositions containing combination of skin care actives |
| IN2000KO00299A (pl) * | 1999-05-28 | 2005-11-18 | Johnson & Johnson Consumer | |
| US6468989B1 (en) * | 2000-07-13 | 2002-10-22 | Dow Pharmaceutical Sciences | Gel compositions containing metronidazole |
| US6387383B1 (en) * | 2000-08-03 | 2002-05-14 | Dow Pharmaceutical Sciences | Topical low-viscosity gel composition |
| WO2002094179A2 (en) * | 2001-05-23 | 2002-11-28 | J.B. Chemicals & Pharmaceuticals Ltd. | Novel topical microbicidal compositions |
| US6881726B2 (en) * | 2001-12-24 | 2005-04-19 | Dow Pharmaceutical Sciences | Aqueous compositions containing metronidazole |
| KR100773537B1 (ko) * | 2003-06-03 | 2007-11-07 | 삼성전자주식회사 | 한 개의 스위칭 소자와 한 개의 저항체를 포함하는비휘발성 메모리 장치 및 그 제조 방법 |
| FR2887149B1 (fr) * | 2005-06-17 | 2007-08-03 | Galderma Sa | Procede de solubilisation du metronidazole |
| KR100626381B1 (ko) * | 2004-07-19 | 2006-09-20 | 삼성전자주식회사 | 상변화 기억 소자 및 그 형성 방법 |
-
2005
- 2005-06-17 FR FR0506182A patent/FR2887149B1/fr not_active Expired - Fee Related
-
2006
- 2006-06-16 SI SI200631390T patent/SI2204174T1/sl unknown
- 2006-06-16 PL PL06778604T patent/PL1896016T3/pl unknown
- 2006-06-16 EP EP10160846A patent/EP2204174B1/fr active Active
- 2006-06-16 DK DK06778604.6T patent/DK1896016T3/da active
- 2006-06-16 DE DE602006016122T patent/DE602006016122D1/de active Active
- 2006-06-16 EP EP06778604A patent/EP1896016B1/fr active Active
- 2006-06-16 ES ES10160846T patent/ES2388236T3/es active Active
- 2006-06-16 DK DK10160846.1T patent/DK2204174T3/da active
- 2006-06-16 PT PT10160846T patent/PT2204174E/pt unknown
- 2006-06-16 WO PCT/FR2006/001367 patent/WO2006134279A2/fr not_active Ceased
- 2006-06-16 CA CA002611883A patent/CA2611883A1/fr not_active Abandoned
- 2006-06-16 SI SI200630757T patent/SI1896016T1/sl unknown
- 2006-06-16 PL PL10160846T patent/PL2204174T3/pl unknown
- 2006-06-16 ES ES06778604T patent/ES2350368T3/es active Active
- 2006-06-16 PT PT06778604T patent/PT1896016E/pt unknown
- 2006-06-16 AT AT06778604T patent/ATE476976T1/de active
-
2007
- 2007-12-17 US US12/000,771 patent/US7981916B2/en active Active
-
2009
- 2009-11-02 US US12/610,996 patent/US20100048645A1/en not_active Abandoned
-
2010
- 2010-09-30 CY CY20101100874T patent/CY1110807T1/el unknown
-
2011
- 2011-05-18 US US13/110,116 patent/US8859603B2/en active Active
-
2012
- 2012-08-13 CY CY20121100735T patent/CY1113401T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2887149A1 (fr) | 2006-12-22 |
| EP1896016A2 (fr) | 2008-03-12 |
| ES2350368T3 (es) | 2011-01-21 |
| EP2204174B1 (fr) | 2012-05-16 |
| WO2006134279A3 (fr) | 2007-02-22 |
| CY1113401T1 (el) | 2016-06-22 |
| US20110217357A1 (en) | 2011-09-08 |
| PL1896016T3 (pl) | 2011-05-31 |
| PT2204174E (pt) | 2012-08-09 |
| US8859603B2 (en) | 2014-10-14 |
| FR2887149B1 (fr) | 2007-08-03 |
| EP2204174A1 (fr) | 2010-07-07 |
| ES2388236T3 (es) | 2012-10-11 |
| SI2204174T1 (sl) | 2012-10-30 |
| PT1896016E (pt) | 2010-11-04 |
| DK1896016T3 (da) | 2010-11-22 |
| CA2611883A1 (fr) | 2006-12-21 |
| SI1896016T1 (sl) | 2010-10-29 |
| WO2006134279A2 (fr) | 2006-12-21 |
| DK2204174T3 (da) | 2012-08-27 |
| DE602006016122D1 (de) | 2010-09-23 |
| EP1896016B1 (fr) | 2010-08-11 |
| ATE476976T1 (de) | 2010-08-15 |
| US7981916B2 (en) | 2011-07-19 |
| CY1110807T1 (el) | 2015-06-10 |
| US20080161375A1 (en) | 2008-07-03 |
| US20100048645A1 (en) | 2010-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110807T1 (el) | Μεθοδος διαλυτοποιησης μετρονιδαζολης | |
| WO2007003962A3 (en) | Gpcr agonists | |
| WO2007003961A3 (en) | Gpcr agonists | |
| EP2023926A4 (en) | PYRIDONECARBOXAMIDE DERIVATIVES USEFUL FOR TREATING HYPERPROLIFERATIVE AND ANGIOGENESIS RELATED DISORDERS | |
| CY1121135T1 (el) | Ενωσεις υποκατεστημενης τετρακυκλιnhς για την θεραπευτικη αγωγη φλεγμονωδων διαταραχων του δερματος | |
| FR2894136B1 (fr) | Article cosmetique soluble moussant | |
| TW200744588A (en) | Pharmaceutical composition for external use | |
| WO2007087395A3 (en) | UNSATURATED mTOR INHIBITORS | |
| WO2010059531A3 (en) | Alpha-keto peracids and methods for producing and using the same | |
| TW200745261A (en) | Aqueous dispersions based on nitrocellulose-polyurethane particles | |
| NO20082376L (no) | Farmasoytiske sammensetninger | |
| WO2007078815A3 (en) | Certain chemical entities, compositions, and methods | |
| WO2008128775A3 (en) | Stabilised pharmaceutical composition containing pregabaline | |
| FI20055416A0 (fi) | Bioabsorvoituva nauhajärjestelmä, bioabsorboituva nauha, menetelmä bioabsorboituvan nauhan valmistamiseksi, bioabsorboituvan nauhan neulajärjestelmä sekä lukitusmekanismi | |
| NO20082097L (no) | Farmasoytiske sammensetninger | |
| WO2007089336A3 (en) | Certain chemical entities, compositions and methods | |
| WO2007070683A3 (en) | Certain chemical entities, compositions and methods | |
| PT2056805E (pt) | Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento de reacção tecidular | |
| MX342124B (es) | Superficie de reaccion hidraulica dirigible. | |
| MX2007007427A (es) | Composicion que comprende adapaleno solubilizado con ciclodextrinas. | |
| TW200745044A (en) | Pyrazole derivatives, compositions containing such compounds and methods of use | |
| WO2007070626A3 (en) | Certain chemical entities, compositions and methods | |
| MX274842B (es) | Procedimiento para la produccion de sales de (4,5-dihidroisoxazol- 3-il)tiocarboxamidina. | |
| MX2008010804A (es) | Derivados de rapamicina para tratar neuroblastoma. | |
| WO2006127706A3 (en) | Method and system of configuring media units |